Moderna pauses plans for Kenya vaccine plant amid declining COVID-19 vaccine demand in Africa. Losses from unfulfilled orders prompt strategic shift. Efforts to finalize deal with Kenyan government ...
Moderna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines.